Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma

Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells

(2015) Elisa Lo Monaco et al.   NEOPLASIA

HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy

(2012) Wei-Hua Yan   Endocrine Metabolic & Immune Disorders-Drug Targets

Human leukocyte antigen-G in cancer: Are they clinically relevant?

(2011) Wei-Hua Yan   CANCER LETTERS

HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer

(2011) Aifen Lin et al.   LUNG CANCER

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

(2011) Michael Campoli et al.   Seminars in Immunopathology

Is there any role for surgery in the multidisciplinary treatment of esophageal cancer?

(2010) M. Stahl   ANNALS OF ONCOLOGY

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

(2010) Federico Garrido et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

HLA-F is a surface marker on activated lymphocytes

(2010) Ni Lee et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

(2010) E. M. de Kruijf et al.   JOURNAL OF IMMUNOLOGY

Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: Association with disease progression

(2009) Qiao Liu et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma

(2008) Y Mizukami et al.   BRITISH JOURNAL OF CANCER